Mei H Y, Cui M, Sutton S T, Truong H N, Chung F Z, Czarnik A W
Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48106, USA.
Nucleic Acids Res. 1996 Dec 15;24(24):5051-3. doi: 10.1093/nar/24.24.5051.
High-throughput screening assays have been developed to rapidly identify small molecule inhibitors targeting catalytic group I introns. Biochemical reactions catalyzed by a self-splicing group I intron derived from Pneumocystis carinii or from bacteriophage T4 have been investigated. In vitro biochemical assays amenable to high-throughput screening have been established. Small molecules that inhibit the functions of group I introns have been identified. These inhibitors should be useful in better understanding ribozyme catalysis or in therapeutic intervention of group I intron-containing microorganisms.
高通量筛选分析方法已被开发出来,用于快速鉴定靶向催化I组内含子的小分子抑制剂。对源自卡氏肺孢子虫或噬菌体T4的自我剪接I组内含子催化的生化反应进行了研究。已建立了适用于高通量筛选的体外生化分析方法。已鉴定出抑制I组内含子功能的小分子。这些抑制剂应有助于更好地理解核酶催化作用,或对含I组内含子的微生物进行治疗干预。